Drug Shortage Report for TEVA-ANASTROZOLE

Last updated on 2020-01-24 History
Report ID 104374
Drug Identification Number 02394898
Brand name ACT ANASTROZOLE
Common or Proper name ANASTROZOLE 1MG FC TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ANASTROZOLE
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30UD
ATC code L02BG
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-22
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-01-24
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-01-24 French Compare
v1 2020-01-24 English Compare